CN Stock MarketDetailed Quotes
900904 Shanghai Shenqi Pharmaceutical Investment Management
- 0.473
- -0.010-2.07%
Market Closed Sep 9 15:00 CST
252.62MMarket Cap29.56P/E (TTM)
0.497High0.471Low1.71KlotVolume0.485Open0.483Pre Close81.81KTurnover0.04%Turnover Ratio31.53P/E (Static)534.07MShares0.78052wk High0.79P/B226.72MFloat Cap0.35652wk Low0.531Limit Up479.32MShs Float2.475Historical High0.435Limit Down5.38%Amplitude-0.004Historical Low0.01Dividend TTM0.478Avg Price1.33KlotAsk2.96%Div YieldTTM100Lot Size365.60lotBid
Shanghai Shenqi Pharmaceutical Investment Management Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -7.91%1.11B | -1.42%574.53M | -2.00%2.34B | -0.13%1.71B | 0.29%1.21B | -0.93%582.8M | 3.72%2.39B | 0.57%1.71B | 4.03%1.2B | 6.41%588.24M |
| Operating revenue | -7.91%1.11B | -1.42%574.53M | -2.00%2.34B | -0.13%1.71B | 0.29%1.21B | -0.93%582.8M | 3.72%2.39B | 0.57%1.71B | 4.03%1.2B | 6.41%588.24M |
| Other operating revenue | 44.59%3.67M | ---- | 212.18%677.34K | ---- | -47.51%2.54M | ---- | -92.58%216.97K | ---- | 130.61%4.83M | ---- |
| Total operating cost | -8.33%1.05B | -1.35%543.62M | -2.75%2.25B | -0.06%1.63B | -0.72%1.15B | -1.32%551.05M | 3.40%2.31B | 0.01%1.63B | 5.93%1.16B | 6.79%558.44M |
| Operating cost | 2.76%584.2M | 8.18%291.96M | 4.19%1.17B | 8.49%825.03M | 1.68%568.51M | 1.43%269.89M | 22.72%1.12B | 10.20%760.5M | 15.28%559.11M | 12.57%266.08M |
| Operating tax surcharges | -10.73%14.72M | -5.25%9.99M | -1.93%29.07M | -5.02%22.73M | 14.06%16.49M | 17.77%10.54M | 8.88%29.64M | 14.09%23.93M | 3.24%14.46M | 16.97%8.95M |
| Operating expense | -21.76%387.48M | -6.80%212.44M | -9.30%909.41M | -7.62%677.56M | -4.03%495.26M | -10.65%227.95M | -11.63%1B | -10.35%733.45M | -2.50%516.04M | 2.92%255.11M |
| Administration expense | -0.04%41.08M | -6.28%18.62M | -1.80%92.53M | -3.28%62.22M | -4.09%41.1M | 2.80%19.86M | -3.07%94.23M | -5.82%64.33M | -5.00%42.85M | -6.91%19.32M |
| Financial expense | -95.13%292.63K | -54.74%1.65M | -10.96%10.92M | -13.11%7.99M | -8.17%6.01M | 25.33%3.64M | 75.16%12.27M | 307.48%9.2M | 326.77%6.55M | 302.95%2.9M |
| -Interest expense (Financial expense) | -26.78%5.65M | -40.85%3.02M | -14.98%14.76M | -14.14%10.9M | -14.41%7.72M | -4.95%5.1M | 108.31%17.37M | 277.67%12.7M | 342.91%9.02M | 425.22%5.37M |
| -Interest Income (Financial expense) | -171.79%-6.43M | -14.37%-1.46M | 19.48%-5.16M | 17.11%-3.62M | 22.96%-2.37M | 38.31%-1.28M | -166.98%-6.41M | -129.92%-4.37M | -193.99%-3.07M | -8,076.76%-2.07M |
| Research and development | 18.14%25.12M | -53.24%8.96M | -29.76%32.3M | -13.82%31.49M | 18.14%21.26M | 215.75%19.16M | -9.73%45.99M | 30.39%36.54M | 4.34%17.99M | -36.43%6.07M |
| Credit Impairment Loss | -159.09%-11.48M | --90.36K | 2,071.77%47.69M | -256.40%-4.38M | -1,493.15%-4.43M | ---- | -109.84%-2.42M | 96.08%-1.23M | 83.34%-278.16K | 379.98%85.84K |
| Asset Impairment Loss | 36.89%-1.32M | ---- | -361.85%-72.41M | 69.97%-2.09M | -3,641.37%-2.09M | ---- | 44.27%-15.68M | -465.93%-6.97M | 112.65%59.12K | ---- |
| Other net revenue | -148.80%-9.57M | -16.12%837.76K | 9.16%-11.8M | 104.87%461.62K | -236.36%-3.85M | 4.38%998.77K | -140.62%-12.99M | -366.89%-9.48M | 52.58%2.82M | -45.06%956.9K |
| Fair value change income | 74.83%45.08K | -112.53%-7.88K | --897.68K | --571.75K | --25.79K | --62.89K | ---- | ---- | ---- | ---- |
| Invest income | ---- | ---- | -54.10%810.17K | ---- | ---- | ---- | -93.72%1.77M | -99.01%300K | -91.21%300K | -81.94%300K |
| -Including: Investment income associates | ---- | ---- | 433.25%347.03K | ---- | ---- | ---- | -89.57%65.08K | ---- | ---- | ---- |
| Asset deal income | 303.77%151.92K | 2,940.58%151.92K | 105.19%268.66K | 100.62%31.85K | -825.49%-74.55K | --5K | -155,514.26%-5.17M | -34,825.21%-5.1M | --10.28K | ---- |
| Other revenue | 11.34%3.04M | -35.18%603.36K | 28.60%10.95M | 80.18%6.33M | -0.04%2.73M | 63.01%930.89K | 14.57%8.51M | -40.30%3.51M | 375.94%2.73M | 371.10%571.06K |
| Operating profit | -9.96%47.9M | -3.06%31.75M | 25.80%82.84M | 11.39%83.98M | 10.71%53.2M | 6.45%32.75M | -34.97%65.85M | -4.40%75.39M | -26.44%48.06M | -2.69%30.76M |
| Add:Non operating Income | -10.96%573.16K | -79.45%28.45K | -0.84%931.93K | -35.75%796.06K | 99.51%643.73K | 6.10%138.46K | 46.44%939.87K | 100.91%1.24M | 3.43%322.66K | -36.80%130.5K |
| Less:Non operating expense | 561.06%1.16M | 3,209.69%389.84K | -89.81%363.16K | 21.36%649.33K | -64.68%175.19K | -83.86%11.78K | 54.29%3.56M | -74.70%535.05K | -75.50%496.06K | -59.41%72.97K |
| Total profit | -11.84%47.32M | -4.53%31.38M | 31.92%83.41M | 10.55%84.12M | 12.09%53.67M | 6.66%32.87M | -36.52%63.23M | -1.64%76.09M | -24.73%47.88M | -2.59%30.82M |
| Less:Income tax cost | -56.03%8.43M | -34.24%6.26M | 68.40%25.15M | -2.54%18.67M | 26.74%19.16M | 32.34%9.52M | -52.79%14.93M | -18.32%19.16M | -22.81%15.12M | -21.22%7.2M |
| Net profit | 12.70%38.89M | 7.59%25.12M | 20.63%58.26M | 14.96%65.45M | 5.33%34.51M | -1.16%23.35M | -28.94%48.29M | 5.61%56.93M | -25.59%32.76M | 4.97%23.62M |
| Net profit from continuing operation | 12.70%38.89M | 7.59%25.12M | 20.63%58.26M | 14.96%65.45M | 5.33%34.51M | -1.16%23.35M | -28.94%48.29M | 5.61%56.93M | -25.59%32.76M | 4.97%23.62M |
| Less:Minority Profit | 564.11%1.05M | 367.98%1.18M | 595.39%1.26M | -133.53%-498.72K | -128.77%-227.1K | -375.76%-439.74K | 84.70%-254.05K | 68.47%1.49M | 329.06%789.35K | -77.45%159.47K |
| Net profit of parent company owners | 8.93%37.84M | 0.65%23.94M | 17.41%57M | 18.94%65.95M | 8.64%34.74M | 1.39%23.79M | -30.27%48.55M | 4.57%55.45M | -27.94%31.97M | 7.64%23.47M |
| Earning per share | ||||||||||
| Basic earning per share | 16.67%0.07 | 0.00%0.04 | 22.22%0.11 | 20.00%0.12 | 0.00%0.06 | 0.00%0.04 | -30.77%0.09 | 0.00%0.1 | -25.00%0.06 | 0.00%0.04 |
| Diluted earning per share | 16.67%0.07 | 0.00%0.04 | 22.22%0.11 | 20.00%0.12 | 0.00%0.06 | 0.00%0.04 | -30.77%0.09 | 0.00%0.1 | -25.00%0.06 | 0.00%0.04 |
| Other composite income | -119.81%-1.32M | -88.74%223.7K | 140.59%4.81M | 127.98%3.67M | 177.52%6.69M | 125.85%1.99M | -198.47%-11.86M | -672.58%-13.11M | -38.43%-8.63M | -29.88%-7.69M |
| Other composite income of parent company owners | -119.81%-1.32M | -88.74%223.7K | 140.59%4.81M | 127.98%3.67M | 177.52%6.69M | 125.85%1.99M | -402.81%-11.86M | -672.58%-13.11M | -38.43%-8.63M | -29.88%-7.69M |
| Total composite income | -8.81%37.57M | 0.03%25.35M | 73.12%63.07M | 57.74%69.12M | 70.70%41.2M | 59.00%25.34M | -43.06%36.43M | -22.02%43.82M | -36.14%24.13M | -3.92%15.94M |
| Total composite income of parent company owners | -11.86%36.51M | -6.24%24.17M | 68.49%61.81M | 64.45%69.62M | 77.45%41.42M | 63.39%25.78M | -45.46%36.69M | -23.47%42.33M | -38.79%23.34M | -0.64%15.78M |
| Total composite income of minority owners | 564.11%1.05M | 367.98%1.18M | 595.39%1.26M | -133.53%-498.72K | -128.77%-227.1K | -375.76%-439.74K | 92.24%-254.05K | 68.47%1.49M | 329.06%789.35K | -77.45%159.47K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- |
| Auditor | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg